Cyclophosphamide Market in Southeast Asia - Manufacturing and Consumption, Outlook and Forecast 2020-2026

April 2020 | 92 pages | ID: CC240DF8C5C4EN
Market Monitor Global

Abstracts

Cyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma.

This report contains market size and forecasts of Cyclophosphamide in Southeast Asia, including the following market information:
Southeast Asia Cyclophosphamide Market Revenue, 2015-2020, 2021-2026, ($ millions)
Southeast Asia Cyclophosphamide Market Consumption, 2015-2020, 2021-2026, (Person)
Southeast Asia Cyclophosphamide Production Capacity, 2015-2020, 2021-2026, (Person)
Top Five Competitors in Southeast Asia Cyclophosphamide Market 2019 (%)
The global Cyclophosphamide market was valued at 648.4 million in 2019 and is projected to reach US$ 702.9 million by 2026, at a CAGR of 2.0% during the forecast period. While the Cyclophosphamide market size in Southeast Asia was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cyclophosphamide manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Cyclophosphamide production and consumption in Southeast Asia

Total Market by Segment:

Southeast Asia Cyclophosphamide Market, By Type, 2015-2020, 2021-2026 ($ millions) & (Person)
Southeast Asia Cyclophosphamide Market Segment Percentages, By Type, 2019 (%)

• High-Dose
• Low-Dose

Southeast Asia Cyclophosphamide Market, By Application, 2015-2020, 2021-2026 ($ millions) & (Person)
Southeast Asia Cyclophosphamide Market Segment Percentages, By Application, 2019 (%)

• Cancer
• Autoimmune Diseases
• AL Amyloidosis
• Others

Competitor Analysis

The report also provides analysis of leading market participants including:
Total Cyclophosphamide Market Competitors Revenues in Southeast Asia, by Players 2015-2020 (Estimated), ($ millions)
Total Cyclophosphamide Market Competitors Revenues Share in Southeast Asia, by Players 2019 (%)
Total Southeast Asia Cyclophosphamide Market Competitors Sales, by Players 2015-2020 (Estimated), (Person)
Total Southeast Asia Cyclophosphamide Market Competitors Sales Market Share by Players 2019 ($ millions)

Further, the report presents profiles of competitors in the market, including the following:

• Baxter
• Novartis
• Hikma Pharmaceuticals
• Amneal Pharmaceuticals LLC
• Jiangsu Hengrui Medicine
• NorthStar Rx LLC
• GLS Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cyclophosphamide Market Definition
1.2 Market Segments
  1.2.1 Segment by Type
  1.2.2 Segment by Application
1.3 Southeast Asia Cyclophosphamide Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 COVID-19 IMPACT: SOUTHEAST ASIA CYCLOPHOSPHAMIDE OVERALL MARKET SIZE

2.1 Southeast Asia Cyclophosphamide Market Size: 2020 VS 2026
2.2 Southeast Asia Cyclophosphamide Revenue, Prospects & Forecasts: 2015-2026
2.3 Southeast Asia Cyclophosphamide Sales (Consumption): 2015-2026

3 COMPANY LANDSCAPE

3.1 Top Cyclophosphamide Players in Southeast Asia (including Foreign and Local Companies)
3.2 Top Southeast Asia Cyclophosphamide Companies Ranked by Revenue
3.3 Southeast Asia Cyclophosphamide Revenue by Companies (including Foreign and Local Companies)
3.4 Southeast Asia Cyclophosphamide Sales by Companies (including Foreign and Local Companies)
3.5 Southeast Asia Cyclophosphamide Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Cyclophosphamide Companies in Southeast Asia, by Revenue in 2019
3.7 Southeast Asia Manufacturers Cyclophosphamide Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cyclophosphamide Players in Southeast Asia
  3.8.1 List of Southeast Asia Tier 1 Cyclophosphamide Companies
  3.8.2 List of Southeast Asia Tier 2 and Tier 3 Cyclophosphamide Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Southeast Asia Cyclophosphamide Market Size Markets, 2020 & 2026
  4.1.2 High-Dose
  4.1.3 Low-Dose
4.2 By Type - Southeast Asia Cyclophosphamide Revenue & Forecasts
  4.2.1 By Type - Southeast Asia Cyclophosphamide Revenue, 2015-2020
  4.2.2 By Type - Southeast Asia Cyclophosphamide Revenue, 2021-2026
  4.2.3 By Type - Southeast Asia Cyclophosphamide Revenue Market Share, 2015-2026
4.3 By Type - Southeast Asia Cyclophosphamide Sales & Forecasts
  4.3.1 By Type - Southeast Asia Cyclophosphamide Sales, 2015-2020
  4.3.2 By Type - Southeast Asia Cyclophosphamide Sales, 2021-2026
  4.3.3 By Type - Southeast Asia Cyclophosphamide Sales Market Share, 2015-2026
4.4 By Type - Southeast Asia Cyclophosphamide Price (Manufacturers Selling Prices), 2015-2026

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Southeast Asia Cyclophosphamide Market Size, 2020 & 2026
  5.1.2 Cancer
  5.1.3 Autoimmune Diseases
  5.1.4 AL Amyloidosis
  5.1.5 Others
5.2 By Application - Southeast Asia Cyclophosphamide Revenue & Forecasts
  5.2.1 By Application - Southeast Asia Cyclophosphamide Revenue, 2015-2020
  5.2.2 By Application - Southeast Asia Cyclophosphamide Revenue, 2021-2026
  5.2.3 By Application - Southeast Asia Cyclophosphamide Revenue Market Share, 2015-2026
5.3 By Application - Southeast Asia Cyclophosphamide Sales & Forecasts
  5.3.1 By Application - Southeast Asia Cyclophosphamide Sales, 2015-2020
  5.3.2 By Application - Southeast Asia Cyclophosphamide Sales, 2021-2026
  5.3.3 By Application - Southeast Asia Cyclophosphamide Sales Market Share, 2015-2026
5.4 By Application - Southeast Asia Cyclophosphamide Price (Manufacturers Selling Prices), 2015-2026

6 MANUFACTURERS & BRANDS PROFILES

6.1 Baxter
  6.1.1 Baxter Corporate Summary
  6.1.2 Baxter Business Overview
  6.1.3 Baxter Cyclophosphamide Major Product Offerings
  6.1.4 Baxter Sales and Revenue in Southeast Asia (2015-2020)
  6.1.5 Baxter Key News
6.2 Novartis
  6.2.1 Novartis Corporate Summary
  6.2.2 Novartis Business Overview
  6.2.3 Novartis Cyclophosphamide Major Product Offerings
  6.2.4 Novartis Sales and Revenue in Southeast Asia (2015-2020)
  6.2.5 Novartis Key News
6.3 Hikma Pharmaceuticals
  6.3.1 Hikma Pharmaceuticals Corporate Summary
  6.3.2 Hikma Pharmaceuticals Business Overview
  6.3.3 Hikma Pharmaceuticals Cyclophosphamide Major Product Offerings
  6.3.4 Hikma Pharmaceuticals Sales and Revenue in Southeast Asia (2015-2020)
  6.3.5 Hikma Pharmaceuticals Key News
6.4 Amneal Pharmaceuticals LLC
  6.4.1 Amneal Pharmaceuticals LLC Corporate Summary
  6.4.2 Amneal Pharmaceuticals LLC Business Overview
  6.4.3 Amneal Pharmaceuticals LLC Cyclophosphamide Major Product Offerings
  6.4.4 Amneal Pharmaceuticals LLC Sales and Revenue in Southeast Asia (2015-2020)
  6.4.5 Amneal Pharmaceuticals LLC Key News
6.5 Jiangsu Hengrui Medicine
  6.5.1 Jiangsu Hengrui Medicine Corporate Summary
  6.5.2 Jiangsu Hengrui Medicine Business Overview
  6.5.3 Jiangsu Hengrui Medicine Cyclophosphamide Major Product Offerings
  6.5.4 Jiangsu Hengrui Medicine Sales and Revenue in Southeast Asia (2015-2020)
  6.5.5 Jiangsu Hengrui Medicine Key News
6.6 NorthStar Rx LLC
  6.6.1 NorthStar Rx LLC Corporate Summary
  6.6.2 NorthStar Rx LLC Business Overview
  6.6.3 NorthStar Rx LLC Cyclophosphamide Major Product Offerings
  6.6.4 NorthStar Rx LLC Sales and Revenue in Southeast Asia (2015-2020)
  6.6.5 NorthStar Rx LLC Key News
6.7 GLS Pharma
  6.6.1 GLS Pharma Corporate Summary
  6.6.2 GLS Pharma Business Overview
  6.6.3 GLS Pharma Cyclophosphamide Major Product Offerings
  6.4.4 GLS Pharma Sales and Revenue in Southeast Asia (2015-2020)
  6.7.5 GLS Pharma Key News
6.8 CSC Pharmaceuticals International
  6.8.1 CSC Pharmaceuticals International Corporate Summary
  6.8.2 CSC Pharmaceuticals International Business Overview
  6.8.3 CSC Pharmaceuticals International Cyclophosphamide Major Product Offerings
  6.8.4 CSC Pharmaceuticals International Sales and Revenue in Southeast Asia (2015-2020)
  6.8.5 CSC Pharmaceuticals International Key News

7 CYCLOPHOSPHAMIDE PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS

7.1 Cyclophosphamide Production Capacity and Value in Southeast Asia, Situation Analysis and Prediction, 2015-2026
  7.1.1 Southeast Asia Cyclophosphamide Production Capacity, 2015-2026
  7.1.2 Southeast Asia Cyclophosphamide Production 2015-2026
  7.1.3 Southeast Asia Cyclophosphamide Production Value 2015-2026
7.2 Key Local Cyclophosphamide Manufacturers in Southeast Asia
  7.2.1 Southeast Asia Key Local Cyclophosphamide Manufacturers Production Capacity
  7.2.2 Southeast Asia Key Local Cyclophosphamide Manufacturers Production
  7.2.3 Southeast Asia Key Local Cyclophosphamide Manufacturers Production Value
  7.2.4 The Proportion of Cyclophosphamide Production Sold in Southeast Asia and Sold Other Than Southeast Asia by Manufacturers
7.3 Cyclophosphamide Export and Import in Southeast Asia
  7.3.1 Southeast Asia Cyclophosphamide Export Market
  7.3.2 Southeast Asia Cyclophosphamide Source of Imports

8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

8.1 PESTLE Analysis for Southeast Asia Cyclophosphamide Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 COVID-19 IMPACT ON CYCLOPHOSPHAMIDE SUPPLY CHAIN ANALYSIS

9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
  9.4.1 Marketing Channels
  9.4.2 Cyclophosphamide Distributors and Sales Agents in Southeast Asia

10 CONCLUSION

11 APPENDIX

11.1 Note
11.2 Examples of Clients
11.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Cyclophosphamide in Southeast Asia
Table 2. Top Players in Southeast Asia, Ranking by Revenue (2019)
Table 3. Southeast Asia Cyclophosphamide Revenue by Companies, (US$, Mn), 2015-2020
Table 4. Southeast Asia Cyclophosphamide Revenue Share by Companies, 2015-2020
Table 5. Southeast Asia Cyclophosphamide Sales by Companies, (Person), 2015-2020
Table 6. Southeast Asia Cyclophosphamide Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Cyclophosphamide Price (2015-2020) (Average Cost/Person)
Table 8. Southeast Asia Manufacturers Cyclophosphamide Product Type
Table 9. List of Southeast Asia Tier 1 Cyclophosphamide Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of Southeast Asia Tier 2 and Tier 3 Cyclophosphamide Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Cyclophosphamide Revenue in Southeast Asia (US$, Mn), 2015-2020
Table 12. By Type - Cyclophosphamide Revenue in Southeast Asia (US$, Mn), 2021-2026
Table 13. By Type - Cyclophosphamide Sales in Southeast Asia (Person), 2015-2020
Table 14. By Type - Cyclophosphamide Sales in Southeast Asia (Person), 2021-2026
Table 15. By Application - Cyclophosphamide Revenue in Southeast Asia, (US$, Mn), 2015-2020
Table 16. By Application - Cyclophosphamide Revenue in Southeast Asia, (US$, Mn), 2021-2026
Table 17. By Application - Cyclophosphamide Sales in Southeast Asia, (Person), 2015-2020
Table 18. By Application - Cyclophosphamide Sales in Southeast Asia, (Person), 2021-2026
Table 19. Baxter Corporate Summary
Table 20. Baxter Cyclophosphamide Product Offerings
Table 21. Baxter Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 22. Novartis Corporate Summary
Table 23. Novartis Cyclophosphamide Product Offerings
Table 24. Novartis Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 25. Hikma Pharmaceuticals Corporate Summary
Table 26. Hikma Pharmaceuticals Cyclophosphamide Product Offerings
Table 27. Hikma Pharmaceuticals Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 28. Amneal Pharmaceuticals LLC Corporate Summary
Table 29. Amneal Pharmaceuticals LLC Cyclophosphamide Product Offerings
Table 30. Amneal Pharmaceuticals LLC Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 31. Jiangsu Hengrui Medicine Corporate Summary
Table 32. Jiangsu Hengrui Medicine Cyclophosphamide Product Offerings
Table 33. Jiangsu Hengrui Medicine Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 34. NorthStar Rx LLC Corporate Summary
Table 35. NorthStar Rx LLC Cyclophosphamide Product Offerings
Table 36. NorthStar Rx LLC Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 37. GLS Pharma Corporate Summary
Table 38. GLS Pharma Cyclophosphamide Product Offerings
Table 39. GLS Pharma Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 40. CSC Pharmaceuticals International Corporate Summary
Table 41. CSC Pharmaceuticals International Cyclophosphamide Product Offerings
Table 42. CSC Pharmaceuticals International Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 43. Cyclophosphamide Production Capacity (Person) of Local Manufacturers in Southeast Asia, 2015-2020
Table 44. Cyclophosphamide Production (Person) of Local Manufacturers in Southeast Asia, 2015-2020
Table 45. Southeast Asia Cyclophosphamide Production Market Share of Local Manufacturers, 2015-2020
Table 46. Cyclophosphamide Production Value (US$, Mn) of Local Manufacturers in Southeast Asia, 2015-2020
Table 47. Southeast Asia Cyclophosphamide Production Value Market Share of Local Manufacturers, 2015-2020
Table 48. The Percentage of Cyclophosphamide Production Sold in Southeast Asia and Sold Other Than Southeast Asia by Manufacturers
Table 49. The Percentage of Cyclophosphamide Production Sold in Southeast Asia and Sold Other Than Southeast Asia by Manufacturers
Table 50. Dangeguojia Cyclophosphamide Sales (Consumption), Production, Export and Import, 2015-2020
Table 51. Raw Materials and Suppliers
Table 52. Cyclophosphamide Downstream Clients in Southeast Asia
Table 53. Cyclophosphamide Distributors and Sales Agents in Southeast Asia

List Of Figures

LIST OF FIGURES

Figure 1. Cyclophosphamide Segment by Type
Figure 2. Cyclophosphamide Segment by Application
Figure 3. Dangeguojia Cyclophosphamide Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Cyclophosphamide Market Size in Southeast Asia, (US$, Mn) & (Person): 2020 VS 2026
Figure 6. Southeast Asia Cyclophosphamide Revenue, 2015-2026 (US$, Mn)
Figure 7. Cyclophosphamide Sales in Southeast Asia: 2015-2026 (Person)
Figure 8. The Top 3 and 5 Players Market Share by Cyclophosphamide Revenue in 2019
Figure 9. By Type - Southeast Asia Cyclophosphamide Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - Southeast Asia Cyclophosphamide Market Share, 2015-2020
Figure 11. By Type - Southeast Asia Cyclophosphamide Market Share, 2020-2026
Figure 12. By Type - Southeast Asia Cyclophosphamide Price (Average Cost/Person), 2015-2026
Figure 13. By Application - Cyclophosphamide Revenue in Southeast Asia (US$, Mn), 2020 & 2026
Figure 14. By Application - Southeast Asia Cyclophosphamide Market Share, 2015-2020
Figure 15. By Application - Southeast Asia Cyclophosphamide Market Share, 2020-2026
Figure 16. By Application -Southeast Asia Cyclophosphamide Price (Average Cost/Person), 2015-2026
Figure 17. Southeast Asia Cyclophosphamide Production Capacity (Person), 2015-2026
Figure 18. Southeast Asia Cyclophosphamide Actual Output (Person), 2015-2026
Figure 19. Southeast Asia Cyclophosphamide Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of Southeast Asia Cyclophosphamide Export Destination, 2019
Figure 21. The Source of Imports of Southeast Asia Cyclophosphamide, 2019
Figure 22. PEST Analysis for Southeast Asia Cyclophosphamide Market in 2020
Figure 23. Cyclophosphamide Market Opportunities & Trends in Southeast Asia
Figure 24. Cyclophosphamide Market Drivers in Southeast Asia
Figure 25. Cyclophosphamide Market Restraints in Southeast Asia
Figure 26. Cyclophosphamide Industry Value Chain